EXECUTIVE ENGAGEMENTS
OUTREACH
7883
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1104
Interactions with Platform & by Email
PARTICIPANTS
236
Unique # Participated
VALIDATIONS
106
Responses Validated*
COMPETITORS
47
Responses Validated*
BRANDS
0
Responses Validated*
* Login for a full stack data experience
DATE
JUL 2020
TABLES
80
PAGES
157
EDITION
9
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Immuno-Oncology estimated at US$63.9 Billion in the year 2020, is projected to reach a revised size of US$163.1 Billion by 2027, growing at a CAGR of 14.3% over the analysis period 2020-2027. Immune Checkpoint Inhibitors, one of the segments analyzed in the report, is projected to record a 14.2% CAGR and reach US$143.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immune System Modulators segment is readjusted to a revised 15% CAGR for the next 7-year period.
The Immuno-Oncology market in the U.S. is estimated at US$18.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.4 Billion by the year 2027 trailing a CAGR of 13.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.7% and 12.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.
In the global Cancer Vaccines segment, USA, Canada, Japan, China and Europe will drive the 15.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$19.5 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 157-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
SELECT PLAYERS
AbbVie, Inc.; Aduro BioTech, Inc.; Amgen, Inc.; AstraZeneca PLC; Bavarian Nordic A/S; Bristol-Myers Squibb Company; Celgene Corporation; Celldex Therapeutics, Inc.; Eli Lilly and Company; EMD Serono, Inc.; F. Hoffmann-La Roche AG; Galena Biopharma, Inc.; Gilead Sciences, Inc.; ImmunoCellular Therapeutics Ltd.; Incyte Corporation; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Prometheus Laboratories, Inc.; Sanofi SA
SEGMENTS
» Cancer Type (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Cancer Types) » Therapy Type (Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Oncolytic Virus, Other Therapy Types)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Immuno-Oncology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Immuno-Oncology Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Immuno-Oncology Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 |
| Immune Checkpoint Inhibitors (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Immune Checkpoint Inhibitors (Therapy Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Immune System Modulators (Therapy Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Immune System Modulators (Therapy Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| Cancer Vaccines (Therapy Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Cancer Vaccines (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Oncolytic Virus (Therapy Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Oncolytic Virus (Therapy Type) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| Other Therapy Types (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Other Therapy Types (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Melanoma (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027 |
| Melanoma (Cancer Type) Market Percentage Share Distribution by Region/Country: 2020 VS 2027 |
| Lung Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027 |
| Lung Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Blood Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2020 to 2027 |
| Blood Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Renal Cell Carcinoma (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Renal Cell Carcinoma (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| Bladder Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Bladder Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Other Cancer Types (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Other Cancer Types (Cancer Type) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Immuno-Oncology Market Share (in %) by Company: 2019 & 2025 |
| United States Immuno-Oncology Market Estimates and Projections in US$ Million by Therapy Type: 2020 to 2027 |
| United States Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| United States Immuno-Oncology Market Estimates and Projections in US$ Million by Cancer Type: 2020 to 2027 |
| United States Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| CANADA |
| Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027 |
| Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027 |
| Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027 |
| Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027 |
| JAPAN |
| Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027 |
| Japanese Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027 |
| Japanese Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| CHINA |
| Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027 |
| Chinese Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027 |
| Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027 |
| Chinese Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027 |
| EUROPE |
| Market Facts & Figures |
| European Immuno-Oncology Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Immuno-Oncology Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| European Immuno-Oncology Market Share Shift by Region/Country: 2020 VS 2027 |
| European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027 |
| European Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027 |
| European Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| FRANCE |
| Immuno-Oncology Market in France by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| Immuno-Oncology Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| GERMANY |
| Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Type for the Period 2020-2027 |
| German Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2020-2027 |
| German Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| ITALY |
| Italian Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027 |
| Italian Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027 |
| Italian Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027 |
| Italian Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027 |
| United Kingdom Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027 |
| United Kingdom Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027 |
| Rest of Europe Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027 |
| Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027 |
| Rest of Europe Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027 |
| ASIA-PACIFIC |
| Immuno-Oncology Market in Asia-Pacific by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027 |
| Immuno-Oncology Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027 |
| REST OF WORLD |
| Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027 |
| Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027 |
| Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027 |
| Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 47 |
| V. CURATED RESEARCH |
